EuroSIDA Publications 2025

  1. Viremia does not independently predict cardiovascular disease in people with HIV: a RESPOND cohort study. Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard H F, Zangerle R, Vehreschild J J, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski J, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O for the RESPOND Study Group.
    Open Forum Infectious Diseases 2025. Jan 13;12(2):ofaf016. Abstract
    ​

  2. Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study. Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen M-C, Wit F, Mussini C, d’Arminio Monforte11 A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski1 N, Volny Anne A, Borodulina E, Ballief M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O and the RESPOND Study Group. 
    European Respiratory Journal 2025. Feb 20:2401904. Abstract
    ​

  3. Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort. Han WM, Ryom L, Sabin C, Greenberg L, Cavassini M, Egle A, Duvivier C, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Miro JM, van der Valk M, Bonnet F, Pradier C, Skocic M, Matulionyte R, Stöckle M, Jaschinski N, Timiryasova A, Tallada J, Rogatto FP, Vannappagari V, Young LA, Lundgren JD, Petoumenos K, Hoy JF. 
    Clinical Infectious Diseases 2025. May 15:ciaf248. Abstract
    ​

  4. Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study. Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Mendes SDS, Tallada J, Kowalska J, Wallner E, Kusejko K, Naschinski N, Lundgren J, Peters L, Reekie J.
    EClinicalMedicine. 2025;89:103521. Abstract
    ​

  5. Use of Preventive Measures for Cardiovascular Disease in People With HIV. Jaschinski N, Neesgaard B, Wit F, Van der Valk M, Kowalska J, Ridolfo AL, Günthard HF, Stöckle M, Wallner E, Nowak P, Castagna A, d'Arminio Monforte A, Petoumenos K, Hoy JF, Hosein S, Lundgren J, Garges H, Rogatto F, Young L, Peters L, Mocroft A, Ryom L; RESPOND Study Group.
    Open Forum Infect Dis. 2025;12(10):ofaf586. Abstract
    ​

  6. Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Bonnet F, Lundgren J, Bottanelli M, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L, On Behalf Of The D A D And Respond Study Groups.
    Cancers (Basel). 2025;17(24):4000. Abstract

  7. Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe. Begré L, Boyd A, Plissonnier ML, Testoni B, Béguelin C, Suter-Riniker F, Scholtès C, Rockstroh JK, Lacombe K, Peters L, Heil M, Levrero M, Rauch A, Zoulim F, Wandeler G; Swiss HIV Cohort Study, EuroSIDA and French HIV/HBV and Biliver cohorts; Members of the EuroSIDA Study Group; Members of the French HIV/HBV and Biliver cohorts.
    JHEP Rep. 2025;8(2):101671.   Abstract

Total number of publications: 352

In Press

  1. Authors reply to "HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications". Kraef C, Ryom L, Kirk O writing group and the RESPOND study group
    European Respiratory Journal, 2025 (in press) 
    ​

  2. Cancer Burden and Risk Factors Among Women with HIV: A Multi-regional Study from the D:A:D and RESPOND Cohort Collaborations. Han WM, Neesgaard B, Knappik M, Cavassini M, Abela IA, Timiryasova A, Greenberg L, Martin C, Mussini C, Wit F, Sabin C, Castagna A, Abutidze A, El-Sadr, W, Bonnet F, Sarcletti M, Carlander C, Hachfeld A, Weis N, Vannappagari V, Rogatto FP, Young LA, Hosein SR, Ryom L, Petoumenos K, on behalf of the D:A:D and RESPOND collaborations
    eClinical Medicine 2025 (in press)